EPARs - Galvus/vildagliptin

FICHA FARMACOLÓGICA de vildagliptin. Contiene la Monografía en distintos idiomas (de la Comunidad Económica Europea), así como la discusión científica que sustenta su aprobación terapéutica. Para acceder a la monografía en idioma español, hacer doble clik en la sigla (es) en la fila que se sitúa más abajo del centro de la página oficial. Cerasale. Marzo 02, 2009.

EPARs for authorised medicinal products for human use - Galvus

Active Substance
vildagliptin
International Nonproprietary Name or Common Name
vildagliptin
Pharmaco-therapeutic Group
Dipeptidyl peptidase 4 (DPP-4) inhibitors
ATC Code
A10BH02

Therapeutic Indication:
Vildagliptin is indicated in the treatment of type 2 diabetes mellitus:

As dual oral therapy in combination with
- metformin, in patients with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin,

- a sulphonylurea, in patients with insufficient glycaemic control despite maximal tolerated dose of a sulphonylurea and for whom metformin is inappropriate due to contraindications or intolerance,

- a thiazolidinedione, in patients with insufficient glycaemic control and for whom the use of a thiazolidinedione is appropriate.